MIRA INFORM REPORT

 

 

Report No. :

303443

Report Date :

19.01.2015

 

IDENTIFICATION DETAILS

 

Name :

QUIMFA S.A.

 

 

Registered Office :

Avda Primer Presidente 1736 Y Calle Yrendague. Asuncion, Republic of Paraguay

 

 

Country :

Paraguay

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

2012

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

Subject is engaged in aims to manufacture and commercialization of medicinal products for human use.

 

 

No. of Employee :

400

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

U$S 200.000

Status :

Satisfactory

Payment Behaviour :

Slow but correct

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

Paraguay

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

PARAGUAY - ECONOMIC OVERVIEW

 

Landlocked Paraguay has a market economy distinguished by a large informal sector, featuring re-export of imported consumer goods to neighboring countries, as well as the activities of thousands of microenterprises and urban street vendors. A large percentage of the population, especially in rural areas, derives its living from agricultural activity, often on a subsistence basis. Because of the importance of the informal sector, accurate economic measures are difficult to obtain. On a per capita basis, real income has stagnated at 1980 levels. The economy grew rapidly between 2003 and 2008 as growing world demand for commodities combined with high prices and favorable weather to support Paraguay's commodity-based export expansion. Paraguay is the sixth largest soy producer in the world. Drought hit in 2008, reducing agricultural exports and slowing the economy even before the onset of the global recession. The economy fell 3.8% in 2009, as lower world demand and commodity prices caused exports to contract. The government reacted by introducing fiscal and monetary stimulus packages. Growth resumed at a 13% level in 2010, the highest in South America, but slowed in 2011-12 as the stimulus subsided and severe drought and outbreaks of foot-and-mouth disease led to a drop in beef and other agricultural exports. The economy took another leap in 2013, largely due to strong export growth. Political uncertainty, corruption, limited progress on structural reform, and deficient infrastructure are the main obstacles to long-term growth.

 

Source : CIA

 

 

 

 


 Registered Name

 

QUIMFA S.A.

RUC 80074991-0

 

 Summary 

 

 

CREATED IN 2012, RELATED COMPANY WITH LA QUIMICA FARMACEUTICA S.A. PROVIDE FIGURES OF BALANCE SHEET AT 31/12/2013 IN GUARANIES. NO NEGATIVE. APT FOR NEW CREDITOS AND ADDITIONAL GUARANTEES.

 

 Operations 

 

 

> PROCESSING AND COMERCIALIZATION OF DRUGS FOR HUMAN USE.

 

 Legal Structure 

 

 

LEGAL FORM:                   PUBLIC LIMITED COMPANY
CREATED:                         2012
REGISTERED:                   2012
DURATION:                         UNLIMITED
END OF FISCAL YEAR:       31.12

 

 Contact 

 

 

MR. LORENZO BRITEZ

Operative address: Avda Primer Presidente 1736 y calle Yrendague. Asuncion, Republic of Paraguay.

Phone.   595.21.281786 and 281794
E-mails: quimfa@quimfa.com.py
              lorenzobritez@quimfa.com.py
Web:     www.quimfa.com.py

 

 Partners 

 

 

PRESIDENT:            OSCAR ARESIO HARRISON JACQUET
DIRECTOR GENERAL:     CHRISTIAN ALDO HARRISON PALEARI
GENERAL MANAGER:      JUSTO RUBEN FERREIRA SERVIN

 

 History 

 

 

Since 2012 have been working in the reference direction. Were initiated by the holder born of a demerger of the QUIMICA FARMACEUTICA S.A. which today only dedicated to imports, which operates in the same direction.

The company aims to manufacture and commercialization of medicinal products for human use.

 

 Economic-Financial Position 

 

 

Figures of Balance Sheet at 31/12/2013, in Guaranies.

Exchange: 1 DOLAR = 4.770 Guaranies.


TOTAL ASSETS...................212.901.359.277

TOTAL LIABILITIES..............191.164.917.939

TOTAL NET WORTH................111.736.441.338

TOTAL LIABILITIES..............212.901.359.277

NET SALES......................105.364.651.931

FINAL RESULT.....................6.088.407.725

 

 Assets 

 

 

REAL ESTATE:
------------
Avda Primer Presidente 1736 y calle Yrendague. Asuncion, Republic of Paraguay.
Surface 27.500 m2 and covered 10.500 m2.

VEHICLES:
---------
6 Trucks Mercedes Benz of different models.

 

 Parent/Related Companies 

 

 

> LA QUIMICA FARMACEUTICA S.A. RUT 80002423.0
> SEGUROS YACIRETA S.A.
> INDUSTRIAS GRAFICAS NOBEL S.A.
> G.T. CIENTIFIC S.A.

 

 Commercial References Consulted 

 

 

> DROGUERIA ITALQUIMICA S.A. DE PARAGUAY
> INDUSTRIAS GRAFICAS NOBEL S.A.PARAGUAY

Payments: 30,60 and 90 days
Credits annuals: U$S 200.000
Concept: Normal

 

 Evolution and Results 

 

 

They are dedicated to the manufacture and comercialization of medicinal products for human use.

Imported from Germany, India, China and countries of Mercosur.

Exported to Bolivia, Uruguay and Peru.

* 400 employees

MAIN SUPPLIERS:
---------------
> DROGUERIA ITALQUIMICA S.A.PARAGUAY
> INDUSTRIAS GRAFICAS NOBEL S.A.PARAGUAY
> G.T. CIENTIFIC S.A.PARAGUAY
> REDOX DISCOUNT S.A.PARAGUAY

 

 Payment Record and Credit Risk 

 

 

> HSBC BANK
> CONTINENTAL
> BBVA PARAGUAY

INSURANCE:
----------
SEGUROS YACIRETA S.A.

 

 Concept 

 

 

Meets the conditions to be treated on credit.

Comes using medium terms and cancellation of all the commitments being done in an orderly and without major constraints

* GOOD GENERAL CONCEPT

 

Final Opinion 

 

 

We conclude this information, understanding as possible taken into account for transactions on credit, working in moderate amounts and with the guarantees of practice.

* SUITABLE FOR A CREDIT TRANSACTIONS

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.89

UK Pound

1

Rs.93.92

Euro

1

Rs.72.00

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

TPT

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.